The Inhibition of Evolocumab on Non-Infarct-Related Artery Disease in Patients with ST-Elevation Myocardial Infarction

PURPOSE: The effects of combing evolocumab and statin on the clinical outcome and physiological function of coronary arteries in STEMI patients with non-infarct-related artery (NIRA) disease are still unclear. METHODS: A total of 355 STEMI patients with NIRA were enrolled in this study, who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qi, Sun, Siyuan, Zhou, Fanghui, Yue, Jingkun, Luo, Xing, Qu, Xiufen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319277/
https://www.ncbi.nlm.nih.gov/pubmed/37408846
http://dx.doi.org/10.2147/IJGM.S417481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319277/
https://www.ncbi.nlm.nih.gov/pubmed/37408846
http://dx.doi.org/10.2147/IJGM.S417481

Ejemplares similares